Evidence map›Paper›PMID 27735840›Full record

ArticleNutrients2016

Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy.

Jose M Colomina, Pere Cavallé-Busquets, Sílvia Fernàndez-Roig, Pol Solé-Navais, Joan D Fernandez-Ballart, Mónica Ballesteros, Per M Ueland, Klaus Meyer, Michelle M Murphy

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01778205 (Phase 1 Study of the Effect of Maternal Nutritional Status on Placental Vascular Function, Fetal Growth and Intrauterine Growth Retardation.), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01778205 completednot on this map

Phase 1 Study of the Effect of Maternal Nutritional Status on Placental Vascular Function, Fetal Growth and Intrauterine Growth Retardation.

TypeobservationalSponsorInstitut Investigacio Sanitaria Pere VirgiliRan2005 to 2020Enrolled831ConditionsIntrauterine DevelopmentArmsObservational
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jose M ColominaArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, Spain. josemaria.colomina@urv.cat.
Pere Cavallé-BusquetsCiberobn Fisiopatología de la Obesidad y Nutrición (CB06/03), Instituto Carlos III, Madrid 28029, Spain. pecavalle@grupsagessa.com.
Sílvia Fernàndez-RoigArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, Spain. silviafroig@gmail.com.
Pol Solé-NavaisArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, Spain. pol.sole@urv.cat.
Joan D Fernandez-BallartArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, Spain. joan.fernandez-ballart@urv.cat.
Mónica BallesterosArea of Obstetrics and Gynaecology, Hospital Universitari Joan XXIII, Tarragona and Universitat Rovira i Virgili, Tarragona 43005, Spain. mobape71@yahoo.es.
Per M UelandSection for Pharmacology, Department of Internal Medicine, University of Bergen, Bergen N-5020, Norway. per.ueland@ikb.uib.no.
Klaus MeyerBevital A/S, Laboratory building, 9th floor, Bergen N-5021, Norway. klaus.meyer@bevital.no.
Michelle M MurphyArea of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV, C/Sant Llorenç 21, Reus 43201, Spain. michelle.murphy@urv.cat.
Instituto de Salud Carlos III · ESBevital (Norway) · NOHospital Universitari Joan XXIII de Tarragona · ESUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of the betaine: homocysteine methyltransferase BHMT c.716G>A (G: guanosine; A: adenosine) single nucleotide polymorphism (SNP) on the BHMT pathway is unknown during pregnancy. We hypothesised that it impairs betaine to dimethylglycine conversion and that folate status modifies its effect. We studied 612 women from the Reus Tarragona Birth Cohort from ≤12 gestational weeks (GW) throughout pregnancy. The frequency of the variant BHMT c.716A allele was 30.8% (95% confidence interval (CI): 28.3, 33.5). In participants with normal-high plasma folate status (>13.4 nmol/L), least square geometric mean [95% CI] plasma dimethylglycine (pDMG, µmol/L) was lower in the GA (2.35 [2.23, 2.47]) versus GG (2.58 [2.46, 2.70]) genotype at ≤12 GW (

conclusionDuring pregnancy, the BHMT pathway is affected by folate status and by the variant BHMT c.716A allele.

Indexed as

Polymorphism, GeneticBetaineBetaine-Homocysteine S-MethyltransferaseFemaleFolic AcidFolic Acid DeficiencyGene Expression RegulationGenotypeHumansMaternal Nutritional Physiological PhenomenaPregnancySarcosineBetaineBetaine-Homocysteine S-MethyltransferaseBHMT protein, humandimethylglycineFolic AcidSarcosineAbetainebetaine: homocysteine methyltransferaseBHMT c.716G&gtdimethylglycinefolatepregnancy

Identifiers

PMID27735840
PMCPMC5084009
OpenAlexW2530198347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.